In organelle imaging, segmentation aims to accurately delineate pixels or voxels corresponding to target organelles from background, noise, and other cellular structures in microscopy images, thereby ...

Meningioma is the most common type of brain tumor. It does not develop in the brain tissue itself, but on the inside of the meninges, the membranes that surround the brain. In most cases, a meningioma ...

Share on Pinterest A new AI tool may help predict disease risk using brain MRI datasets. Image credit: Tunvarat Pruksachat/Getty Images The wellness of the brain plays an important role in living a ...

MADISON (WKOW) — Dr. Mahua Dey, a neurosurgeon at UW Health Carbone Cancer Center, is researching a personalized vaccine to fight glioblastomas, a deadly brain cancer. Dey's approach combines clinical ...

Scientists have discovered a molecule that shrinks brain tumors in mice, raising hopes that the compound could one day become a pill to treat glioblastoma, one of the world’s most pernicious cancers.

Abstract: Medical image processing is highly developed and critical in the medical field, encompassing methods like X-rays, MRI, and CT scans. These techniques help to identify minute defects in the ...

Paxalisib showed a 3.8-month improvement in overall survival for GBM patients, with the FDA considering standard approval based on phase 2/3 trial data. BA-101 received orphan drug designation, ...

Jason Collins announced in September that he was battling a brain tumor. This week, the 13-year NBA veteran player and league ambassador — famously the first pro athlete to come out as gay while still ...

Researchers have solved the decades-old mystery behind how a common pregnancy drug lowers blood pressure. It turns out the medication blocks a fast-acting “oxygen alarm” inside cells. That same alarm ...

DURHAM, N.C. (WTVD) -- It's the second day of Onyx Williams stealing all of our hearts. Wednesday was a typical day at home as he played with his toys and learned. The four-year-old is battling ...

An international clinical study led by the Medical University of Vienna shows that the drug patritumab deruxtecan (HER3-DXd) can have a promising effect in patients with active brain metastases of ...